Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

Item

http://www.wikidata.org/entity/Q24537620

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR

@nl

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@ast

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@en

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@en-gb

type

Item

label

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR

@nl

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@ast

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@en

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@en-gb

prefLabel

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR

@nl

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@ast

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@en

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@en-gb

P1476

Structural modeling extends QSAR analysis of antibody-lysozyme interactions to 3D-QSAR.

@en

P2093

Eva K Freyhult

http://www.w3.org/2001/XMLSchema#string

Karl Andersson

http://www.w3.org/2001/XMLSchema#string

Mats G Gustafsson

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme

The rational construction of an antibody against cystatin: lessons from the crystal structure of an artificial Fab fragment

Beware of q2!

Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions

Lipocalins as a scaffold.

Recognition of spatial motifs in protein structures.

Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.

Predicting the kinetics of peptide-antibody interactions using a multivariate experimental design of sequence and chemical space.

Kinetic and affinity predictions of a protein-protein interaction using multivariate experimental design.

Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate.

P304

2264-2272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0006-3495(03)75032-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12668435

http://www.w3.org/2001/XMLSchema#string

P921

Biofiseg

antibody

P932

1302793

http://www.w3.org/2001/XMLSchema#string